In addition to discovering that the AKT/mTOR pathway is involved in regulating the progression of bladder cancer, we also identified downstream target proteins (c-Myc, SLC25A19, and ICAM5) of UCHL5 by RNA-Seq. This evidence concerns the gene MTOR and urinary bladder carcinoma.